Trellus Health plc announced that Dr. Marla Dubinsky, Co-Founder, who has served the Company and its shareholders as a Non-executive Director since July 2020, will assume the role of CEO with immediate effect. To accommodate this new role, Dr. Dubinsky is reducing other commitments during her tenure as Trellus Health's CEO. Monique Fayad is standing down as CEO and from the Board of Trellus Health with immediate effect, and will continue to offer consultancy services to the Company for a six-month handover period.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 GBX | -.--% | -12.12% | -55.38% |
04-24 | Transcript : Trellus Health plc, Q4 2023 Earnings Call, Apr 24, 2024 | |
04-23 | EARNINGS: Videndum warns on recovery; AB Dynamics expects profit beat | AN |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-55.38% | 2.98M | |
+10.52% | 3,085B | |
+8.91% | 85.92B | |
+5.14% | 77.91B | |
-16.20% | 52.89B | |
+26.18% | 48.28B | |
+28.93% | 45.38B | |
-34.05% | 40.83B | |
+66.72% | 38.78B | |
-0.36% | 27.48B |
- Stock Market
- Equities
- TRLS Stock
- News Trellus Health plc
- Trellus Health Announces Executive Changes